Latest News
Enbridge is a Canadian midstream giant, but it comes with an interesting twist.
Via The Motley Fool · December 24, 2025
Rivian received a vote of confidence and a boost in stock price recently. Here's why there could be more room to run.
Via The Motley Fool · December 24, 2025
Building an Emergency Fund on a Modest Income
Unexpected expenses do not care how tight your budget is. A flat tire, a lost shift at work, a sick pet, a higher heating bill in winter — any of these can throw off your month if every dollar already has a job. An emergency fund is simply a small pile of money that keeps [...]
Via Visibility · December 23, 2025
Could Crocs be more than just a fad? Join us as we evaluate the company's strengths and weaknesses, and discover if this stock is a hidden gem waiting to be uncovered.
Via The Motley Fool · December 24, 2025
Camtek just printed its strongest quarter ever, but one investor quietly took chips off the table, and the timing says a lot about how professionals think after big semiconductor rallies.
Via The Motley Fool · December 24, 2025
With Huntsman trading near multi-year lows, one manager appears to be betting that cash flow and restructuring matter more than near-term earnings pain.
Via The Motley Fool · December 24, 2025
Two analysts waxed bullish on the future of the company.
Via The Motley Fool · December 24, 2025
This high-yielding stock faces some near-term challenges.
Via The Motley Fool · December 24, 2025
With energy prices swinging and capital discipline under pressure, one manager is quietly dialing back risk in a stock that has punished even patient holders.
Via The Motley Fool · December 24, 2025
Ex-president Donald Trump and first lady Melania took part in NORAD's Santa Tracker hotline, fielding calls and joking about cookies and coal.
Via Benzinga · December 24, 2025
This biotech innovator in inhaled therapeutics reported a notable insider sale amid ongoing product development and licensing activity.
Via The Motley Fool · December 24, 2025
With cash piling up, debt rolling off, and shareholder returns accelerating, one small fund is stepping into a battered energy name at a moment when the fundamentals look steadier than the stock.
Via The Motley Fool · December 24, 2025
Emerging market equities bounced back in a big way in 2025, highlighting the advantages of this cheap-to-own Vanguard ETF.
Via The Motley Fool · December 24, 2025
The company has promising technology, but will it be commercially viable?
Via The Motley Fool · December 24, 2025
The company just might have a winner on its hands with a pipeline heart disease treatment.
Via The Motley Fool · December 24, 2025
Via Benzinga · December 24, 2025
Since the turn of the century, central banks have been steadily increasing their gold reserves, a trend that has sharply accelerated in the last few years.
Via Talk Markets · December 24, 2025
USA Rare Earth could be shaping up for a game-changing year in 2026.
Via The Motley Fool · December 24, 2025
If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today.
Via The Motley Fool · December 24, 2025
This company is expected to deliver solid, yet unspectacular, growth in 2026.
Via The Motley Fool · December 24, 2025
The company is on the brink of commercializing a unique medication.
Via The Motley Fool · December 24, 2025
The two things that typically feature in an empire’s last chapters are excess spending...and unnecessary war. Both are self-inflicted wounds that fester…and eventually kill the host.
Via Talk Markets · December 24, 2025
As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D out-of-pocket caps and shifting regulatory winds, two specific "growth pockets"—animal health and specialty/complex generics—have captured investor
Via MarketMinute · December 24, 2025
As the sun sets on 2025, the U.S. housing market stands at a fascinating crossroads. For much of the year, investors and homebuyers alike were held captive by the Federal Reserve's "higher-for-longer" interest rate narrative. Yet, against a backdrop of mortgage rates that stubbornly refused to retreat to the
Via MarketMinute · December 24, 2025
As 2025 draws to a close, a striking divergence has emerged in the equity markets. While the broader indices have grappled with the "tug-of-war" between Federal Reserve policy shifts and persistent inflationary pressures, the Real Estate Investment Trust (REIT) sector has found a second wind. Specifically, residential and healthcare REITs
Via MarketMinute · December 24, 2025